IQVIA(IQV) ZACKS·2025-02-06 18:51Core Insights - IQVIA Holdings Analytics Inc. reported strong fourth-quarter 2024 results, with earnings and revenues exceeding the Zacks Consensus Estimate [1][2] Financial Performance - Adjusted earnings were $3.12 per share, a 9.9% increase year-over-year, slightly above the consensus estimate [2] - Total revenues reached $4 billion, surpassing the consensus estimate and growing 2.3% from the previous year [2] - Adjusted EBITDA for the quarter was $996 million, a 3.1% rise from the year-ago quarter, but below the projection of $1 billion [5] Segment Performance - Research and Development segment revenues were $2.1 billion, a 1.3% increase year-over-year, but missed the estimate of $2.2 billion [3] - Technology and Analytics segment revenues grew 8.3% year-over-year to $1.7 billion, beating the estimate of $1.6 billion [4] - Contract Sales & Medical Solutions revenues decreased 4.8% year-over-year to $177 million, missing the projection of $187 million [4] Cash Flow and Debt - Net cash generated from operating activities was $885 million, with capital expenditure at $164 million, resulting in free cash flow of $721 million [6] - Cash and cash equivalents at the end of the quarter were $1.7 billion, up from $1.6 billion in the previous quarter, while long-term debt increased to $12.8 billion from $12.3 billion [5] 2025 Guidance - Revenue guidance for 2025 was raised to $15.72-$16.12 billion, although the midpoint is lower than the Zacks Consensus Estimate of $16.02 billion [7] - Adjusted EPS guidance was increased to $11.70-$12.10, with the midpoint exceeding the Zacks Consensus Estimate of $11.8 per share [8] - Adjusted EBITDA guidance for 2025 was raised to $3.76-$3.88 billion, compared to the previous estimate of $3.67-$3.70 billion [8]